Enterprise Overview
RCM Applied sciences, Inc. (NasdaqGM: RCMT) operates as a premier supplier of enterprise and know-how options, using its expertise base throughout key market segments to boost the operational efficiency of its purchasers. The Firm’s core mission is centered on serving to to design, construct, and allow the “Industries of Tomorrow, Right this moment”. Strategically working on the intersection of sources, important infrastructure, and industrial modernization, RCM supplies specialised providers throughout a number of domains. These domains embody Healthcare, Engineering, Aerospace & Protection, Course of & Industrial, Life Sciences, and Information & Options. The Firm deploys superior engineering, specialty healthcare, and data know-how providers to handle its prospects’ operational necessities.
Key Monetary Efficiency Highlights
Fourth Quarter 2025
For the present quarter, which consisted of fourteen weeks, RCM Applied sciences reported whole income of $86.476 million. This represents a rise of 12.4% in comparison with the $76.912 million reported throughout the 13 weeks ended December 28, 2024 (the comparable prior quarter). Value of providers for the quarter scaled to $62.198 million from $55.343 million within the prior 12 months. Consequently, gross revenue stood at $24.278 million, demonstrating a 12.6% year-over-year enhance from $21.569 million within the comparable prior quarter.
Working earnings for the quarter improved materially to $7.971 million, up from $6.285 million in This fall 2024. The Firm skilled a discount in earnings tax expense, which fell to $1.087 million from $2.902 million within the comparable interval. This culminated in a GAAP internet earnings of $6.104 million, or $0.80 per diluted share, a considerable enhance in contrast with $2.867 million, or $0.37 per diluted share, within the prior 12 months’s quarter. The diluted weighted common shares excellent decreased to 7,587,448 from 7,733,142 within the comparable quarter.
Fiscal Yr 2025
For the present fiscal 12 months (fifty-three weeks), the Firm generated whole income of $319.404 million. This marks a 14.7% enhance over the $278.380 million generated within the fifty-two weeks ended December 28, 2024. Value of providers for the 12 months was $231.461 million in comparison with $198.602 million within the prior 12 months. Gross revenue for the 12 months reached $87.943 million, reflecting a ten.2% enhance from the $79.778 million reported within the previous 12 months.
Promoting, normal, and administrative (SG&A) bills elevated to $60.932 million from $56.787 million in FY 2024. The Firm’s consolidated working earnings for the 12 months was $25.093 million, up from $22.325 million. GAAP internet earnings for the fiscal 12 months aggregated to $16.334 million, or $2.14 per diluted share, in comparison with $13.327 million, or $1.68 per diluted share, throughout the comparable prior 12 months. The diluted weighted common shares excellent for the 12 months have been 7,635,740, down from 7,939,381 in FY 2024.
Section-Smart Efficiency Evaluation
RCM Applied sciences segments its operational reporting into three distinct classes: Specialty Well being Care; Engineering; and Life Sciences, Information and Options.
Specialty Well being Care
- This fall 2025: Income was $47.999 million, up from $41.011 million in This fall 2024. Gross revenue for the section reached $13.932 million in comparison with $12.537 million within the prior 12 months’s quarter. Nonetheless, the gross revenue margin contracted to 29.0% from 30.6% in This fall 2024.
- FY 2025: Income elevated to $164.104 million from $142.679 million in FY 2024. Gross revenue grew to $47.402 million from $42.533 million, whereas the gross revenue margin skilled a slight compression to twenty-eight.9% from 29.8% within the previous 12 months.
Engineering
- This fall 2025: The section generated $30.404 million in income, in comparison with $26.279 million in This fall 2024. Gross revenue expanded considerably to $7.796 million from $5.181 million. Moreover, the section’s gross revenue margin improved dramatically by 590 foundation factors, reaching 25.6% in comparison with 19.7% within the prior 12 months’s quarter.
- FY 2025: Income totaled $120.486 million, up from $96.459 million within the prior 12 months. Gross revenue grew to $27.382 million from $22.543 million, although the gross revenue margin declined barely to 22.7% from 23.4% year-over-year.
Life Sciences, Information and Options
- This fall 2025: Income declined to $8.073 million from $9.622 million in This fall 2024. Gross revenue decreased proportionally to $2.550 million from $3.851 million, leading to a margin compression to 31.6% from 40.0% within the comparable prior quarter.
- FY 2025: Income contracted to $34.814 million from $39.242 million in FY 2024. Gross revenue fell to $13.159 million from $14.702 million, however the gross revenue margin expanded barely to 37.8% from 37.5% year-over-year.
Operational Metrics and Key Drivers
The Firm depends closely on non-GAAP monetary measures to complement its GAAP reporting, particularly highlighting Adjusted working earnings, EBITDA, Adjusted EBITDA, Adjusted internet earnings, and Adjusted diluted internet earnings per share.
- Adjusted EBITDA: For the present quarter, Adjusted EBITDA elevated by 49.0% to $9.318 million, in comparison with $6.254 million within the comparable prior quarter. For the fiscal 12 months, Adjusted EBITDA rose by 18.9% to $30.743 million, up from $25.855 million in FY 2024.
- Adjusted Web Earnings Per Diluted Share: The Firm reported $0.77 for the present quarter in comparison with $0.49 within the prior quarter. On an annual foundation, this metric elevated to $2.50 per share from $2.03 per share within the comparable prior 12 months.
Key Changes to Non-GAAP Metrics: A number of changes bridged the hole between GAAP working earnings and Adjusted working earnings. Notably, the Firm recorded a positive remeasurement of contingent consideration amounting to ($1.759) million in each This fall 2025 and FY 2025. Changes for fairness compensation have been $0.793 million for This fall 2025 (vs. $0.710 million in This fall 2024) and $3.732 million for FY 2025 (vs. $2.864 million in FY 2024). The Firm additionally recorded an impairment of intangible property amounting to $0.547 million within the present quarter and financial 12 months.
For the calculation of Adjusted internet earnings, a tax impression from a normalized price was utilized, using an estimated efficient earnings tax price of 27.0% for each intervals introduced. This price approximates the Firm’s federal USA earnings tax price plus the tax-affected price for states and Puerto Rico. The precise tax impression adjustment from the normalized price was ($1.068) million for This fall 2025 and ($1.324) million for FY 2025.
Stability Sheet and Liquidity Evaluation
A overview of the Condensed Consolidated Stability Sheets supplies perception into the Firm’s capitalization and dealing capital place at year-end.
- Belongings: Whole property elevated to $134.397 million as of January 3, 2026, from $132.077 million at December 28, 2024. Money and money equivalents decreased from $4.729 million to $2.922 million. Accounts receivable (internet of provision for credit score losses) grew to $81.243 million from $77.960 million. The availability for credit score losses decreased to $1.229 million from $1.570 million.
- Liabilities: Whole liabilities decreased considerably to $88.423 million from $98.593 million. This discount was largely pushed by a big lower in borrowings below the road of credit score, which fell to $24.673 million from $34.967 million within the prior 12 months. Present liabilities remained comparatively secure at $53.884 million, in comparison with $53.633 million on the finish of FY 2024. Accounts payable and accrued bills decreased to $9.649 million from $13.369 million, and transit accounts payable decreased to $16.247 million from $23.870 million. Deferred income in present liabilities grew to $14.761 million from $4.163 million.
- Stockholders’ Fairness: Whole stockholders’ fairness improved to $45.974 million from $33.484 million. This was supported by a rise in retained earnings, although accrued deficit expanded to ($84.752) million from ($77.393) million. The Firm additionally elevated its holdings of treasury inventory, which rose to 10,652,841 shares on the finish of FY 2025, in comparison with 10,236,259 shares on the finish of FY 2024, indicating share repurchase exercise throughout the 12 months.
Money Move Dynamics: Money stream operations exhibited variability. For This fall 2025, internet money offered by working actions was $11.445 million, a powerful reversal from the online money utilized in working actions of ($1.637) million in This fall 2024. Nonetheless, on a full-year foundation, internet money offered by working actions declined to $6.170 million in FY 2025, down from $18.965 million in FY 2024. Web money utilized in investing actions for FY 2025 was $2.572 million, in comparison with $1.595 million within the prior 12 months. Web money utilized in financing actions for FY 2025 was $4.828 million, representing a steep discount from the $19.038 million utilized in FY 2024. General, money and money equivalents decreased by ($1.807) million over the course of the fiscal 12 months.
Administration Commentary and Strategic Updates
Administration explicitly said that the non-GAAP monetary measures offered are supposed as helpful data for buyers, shareholders, and stakeholders to gauge operational outcomes on an ongoing foundation and improve the understanding of present monetary efficiency and period-to-period comparisons. Administration cautions that these metrics shouldn’t be thought of alternate options to GAAP working earnings or internet earnings as efficiency indicators, nor do they account for adjustments in property, liabilities, curiosity, or earnings taxes that have an effect on money flows. The Firm emphasised that these measures ought to solely be learn at the side of the GAAP consolidated monetary statements.
Strategically, RCM Applied sciences opted to not maintain a convention name to debate these quarterly and financial 12 months outcomes. Buyers in search of further data are directed by administration to seek the advice of the Firm’s Kind 10-Okay.
Notable Dangers and Challenges
The Firm’s earnings launch consists of complete forward-looking assertion disclosures, highlighting a number of inherent dangers and uncertainties. Administration notes that expectations concerning future revenues, monetary outcomes, money flows, pipeline developments, potential challenge wins, and enterprise development investments are topic to variables that might trigger precise occasions to vary materially.
These projections are primarily based on assumptions shaped by administration’s expertise, historic development perceptions, and expectations of future developments. The Firm explicitly directs buyers to think about the particular dangers, uncertainties, and different elements detailed in its filings with the Securities and Change Fee, together with the Annual Report on Kind 10-Okay and Quarterly Studies on Kind 10-Q. RCM Applied sciences disclaims any obligation to replace its forward-looking statements in response to new data or future occasions, besides the place required by legislation.
